Squamous cell carcinoma of the tongue: The prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study

Cancer Letters

Volumn 186, Issue 2, 2002, Pages 137-150

  Nagler, Rafael M ^a   Kerner, Hedviga ^a   Laufer, Dov ^a   Ben Eliezer, Shoshana ^a   Minkov, Ira ^a   Ben Itzhak, Ofer ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Bcl 2; C erbB 2; P53; Squamous cell carcinoma; Terminal dUTP nick end labelling; Tongue

Indexed keywords

BIOLOGICAL MARKER; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; ONCOGENE C ERB; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SMOKING; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TONGUE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; TIME FACTORS; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037027750     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00265-3     Document Type: Article

References (60)

1. Kantola S., Parikka M., Jokinen K., Hyrynkangs K., Soini Y., Alho O.P., Salo T. Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br. J. Cancer. 83:2000;614-619.
2. Myers J.N., Elkins T., Roberts D., Byers R.M. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol. Head Neck Surg. 122:2000;44-51.
3. Alho O.P., Kantola S., Pirkola U., Laara E., Jokinen K., Pukkala E. Cancer of the mobile tongue in Finland - increasing incidence, but improved survival. Acta Oncol. 38:1999;1021-1024.
4. Nagler R.M., Braun Y., Daitzchman M., Laufer D. Spiral CT angiography - an alternative vascular evaluation technique for head and neck microvascular reconstruction: a preliminary experience. Plast. Reconst. Surg. 100:1997;1697-1703.
5. Ribeiro K.C., Kowalski L.P., Latorre M.R. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch. Otolaryngol. Head Neck Surg. 126:2000;1079-1085.
6. Yeole B.B., Sankaranarayanan R., Sunny M.S.L., Swaminathan R., Parkin D.M. Survival from head and neck cancer in Mumbai (Bombay), India. Cancer. 89:2000;437-444.
7. Muir C., Weiland L. Upper aerodigestive tract cancers. Cancer. 75:1995;147-153.
8. Jackson M.S., Wrench A.A., Soutar D.S., Robertson A.G. Carcinoma of the tongue: the speech therapist's perspective. Br. J. Oral Maxillofac. Surg. 37:1999;200-204.
9. Nagler R.M., Barak M., Ben-Aryeh H., Peled M., Filatov M., Laufer D. Early diagnostic and treatment monitoring role of Cyfra, 21-1 and TPS in oral squamous cell carcinoma. Cancer. 35:1999;1018-1025.
10. Ben-Sasson S.A., Sherman Y., Gavrieli Y. Identification of dying cells - in situ staining. Methods Cell Biol. 46:1995;29-39.
11. Xie X., Clausen O.P.F., De Angelis P., Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer. 86:1999;913-920.
12. Ravi D., Ramaads K., Mathew B.S., Valinakumarit K.R., Nair M.K., Pillai M.R. De novo programmed cell death in oral cancer. Histopathology. 34:1999;241-249.
13. Attardi L.D., Lowe S.W., Brugarolas J., Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15:1996;3693-3701.
14. Barnard G.A. Significance tests for 2x2 tables. Biometrika. 34:1947;123-138.
15. Irwin J.O. Tests of significance for differences between percentages based on small numbers. Merton. 12:1935;83-94.
16. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
17. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:1966;457-481.
18. Loree T.R., Strong E.W. Significance of positive margins in oral cavity squamous carcinoma. Am. J. Surg. 160:1990;410-414.
19. Woolgar J.A., Birne J.C., Vaughan E.D., Lewis-Jones H.G., Scott J., Brown J.S. Correlation of histopathological findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int. J. Oral Maxillofac. Surg. 24:1995;30-37.
20. Yuen A.P., Lam K., Chan A.C., Wei W.I., Lam L.K., Ho W.K., Ho C.M. Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma. Am. J. Surg. 177:1999;90-92.
21. Haddadin K.J., Soutar D.S., Oliver R.J., Webster M.H., Robertson A.G., Macdonald D.G. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck. 12:1999;517-525.
22. Tiwari R.M., Van Ardenne A., Leemans C.R., Quak J.J., Tobi H., Mehta D.M., Snow G.B. Advanced squamous cell carcinoma of the base of the tongue treated with surgery and post-operative radiotherapy. Eur. J. Surg. Oncol. 26:2000;556-560.
23. El-Husseiny G., Kandil A., Jamshed A., Khafaga Y., Saleem M., Allam A. Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors. Br. J. Oral Maxillofac. Surg. 38:2000;193-199.
24. Nagler R.M., Peled M., Laufer D. Facial trauma - characteristics and therapy. Harefuah. 132:1997;6-10.
25. Holleb A.I., Fink D.J., Murphy G.P. Textbook of Clinical Oncology. 1991;American Cancer Society, Atlanta, GA.
26. Koch W.M., Lango M., Sewell D., Zahurak M., Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope. 109:1999;1544-1551.
27. Spiro R.H., Guillamondegui O. Jr., Paulino A.F., Huvos A.G. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck. 21:1999;408-413.
28. Union Internationale Contre le Cancer (International Union Against Cancer), TNM Classification of Malignant Tumours, 4th Edition, Springer-Verlag, Berlin, 1987.
29. Virag M., Uglesic V., Aljinovic N., Jurlina M. Are the new staging rules better for t4 oral cancer? Am. J. Surg. 170:1995;432-435.
30. Rapidis A.D., Langdon J.D., Patel M.F., Harvey P.W. STNMP: a new system for the clinico-pathological classification and identification of intra-oral cancer. Cancer. 39:1997;204-209.
31. Howaldt H.-P., Frenz M., Pitz H. Proposal for a modified T-classification for oral cancer. J. Cranio-Maxillo-Fac. Surg. 23:1992;96-106.
32. Lydiatt D.D., Robbins K.T., Byers R.M., Wolf P.F. Treatment of stage I and II oral tongue cancer. Head Neck. 15:1993;308-312.
33. Woolgar J.A., Scott J., Vaughan E.D., Brown J.S., West C.R., Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann. R. Coll. Surg. Engl. 77:1995;325-331.
34. Field J.K. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur. J. Cancer B Oral Oncol. 28B:1992;67-76.
35. Field J.K., Spandidos D.A., Yiagnisis M., Gosney J.R., Papadimitriou K., Stell P.M. C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Responsibility. 12:1992;613-616.
36. Wilkman T.S.E., Hietanen J.H.P., Malmström M.J., Konttinen Y.T. Immunohistochemical analysis of the oncoprotein c-erbB-2 expression in oral benign and malignant lesions. Int. J. Oral Maxillofac. Surg. 27:1998;209-212.
37. Werkmeister R., Brandt B., Joos U. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol. 31:(6):2000;100-105.
38. Husain Z., Fei Y., Roy S., Solt D.B., Polverini P.J., Biswas D.K. Sequential expression and cooperative interaction of c-ha-ras and c-erbB genes in in vivo chemical carcinogenesis. Proc. Natl. Acad. Sci. USA. 86:1989;1264-1268.
39. Wong D.T.W., Biswas D.K. Expression of c-erbB proto-oncogene during dimethylbenzanthracene-induced tumorigenesis in hamster cheek pouch. Oncogene. 2:1987;67-72.
40. Wong D.T.W. Amplification of the c-erbB1 oncogene in chemically-induced oral carcinomas. Carcinogenesis. 8:1987;1963-1965.
41. Saranath D., Panchal R.G., Nair R., Mehta A.R., Sanghavi V.D., Deo M.G. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Eur. J. Cancer B Oral Oncol. 28B:1992;139-143.
42. Sugano S., Mukai K., Tsuda H., Hirohashi S., Furuya S., Shimosato Y. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope. 102:1992;923-927.
43. Pinto A.E., Fonseca I., Martins C., Soares J. Objective biologic parameters and their clinical relevance in assessing salivary gland neoplasms. Adv. Anat. Pathol. 7:2000;294-306.
44. Loro L.L., Vintermyr O.K., Liavaag P.G., Jonsson R., Johannessen A.C. Oral squamous cell carcinoma is associated with decreased Bcl-2/Bax expression ratio and increased apoptosis. Hum. Pathol. 30:1999;1097-1105.
45. Ravi D., Ramadas K., Mathew B.S., Nalinakumari K.R., Nair M.K., Pillai M.R. Angiogenesis during tumour progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Oral Oncol. 34:1998;543-548.
46. Xie X., De Angelis P., Clausen O.P.F., Boysen M. Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol. 35:1999;502-509.
47. Shintani S., Mihara M., Nakahara Y., Terakado N., Yoshihama Y., Kiyota A. Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomas. Cancer Lett. 154:2000;71-77.
48. Wyllie A.H., Bellamy C.O., Bubb V.J., Clarke A.R., Corbet S., Curtis L. Apoptosis and carcinogenesis. Br. J. Cancer. 80:1999;34-37.
49. Finlay C.A., Hinds P.W., Tan T.H., Eliyahu D., Oren M., Levine A.J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol. 8:1988;531-539.
50. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 21:1995;1465-1468.
51. Yao L., Iwai M., Furuta L. Correlations of Bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol. 35:1999;56-62.
52. Nishimura A. Changes in Bcl-2 and Bax expression in rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. J. Dent. Responsibility. 78:1999;1264-1269.
53. Lingen M.W., Chang K.W., McMurray S.J., Solt D.B., Kies M.S., Mittal B.B. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 22:2000;328-335.
54. Hogmo A., Kuylenstierna R., Lindholm J., Munck-Wikland E. Predictive value of malignancy grading systems, DNA content, p53, and angiogenesis for Stage I tongue carcinomas. J. Clin. Pathol. 52:1999;35-40.
55. Unal O.F., Ayhan A., Hosal A.S. Prognostic value of p53 expression and histopathological parameters in squamous cell carcinoma of oral tongue. J. Laryngol. Otol. 113:1999;446-450.
56. Levine A.I. P53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
57. Piffko J., Bankfalvi A., Tory K., Fuzesi L., Bryne M., Ofner D. Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas. Head Neck. 12:1998;8-15.
58. Pich A., Margaria E., Chiusa L. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival. J. Clin. Oncol. 18:2000;2948-2956.
59. Ravi D., Nalinakumari K.R., Rajaram R.S., Nair M.K., Pillai M.R. Expression of programmed cell death regulatory p53 and Bcl-2 proteins in oral lesions. Cancer Lett. 105:1996;139-146.
60. Jordan R.C., Catzavelos G.C., Barrett A.W., Speight P.M. Differential expression of Bcl-2 and Bax in squamous cell carcinomas of the oral cavity. Eur. J. Cancer B Oral Oncol. 32:1996;394-400.